PODD Cash & equivalents
Cash & equivalents at Insulet Corporation fell to $716M in fiscal 2025, from $953M in 2024.
Cash and cash equivalents at year end, as filed.
SOURCE: us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · EDGAR CompanyFacts · CIK 1145197 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
FY2025$716M
FY2024 $953M
HIGH$953M FY2024
LOW$690M FY2022
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Cash & equivalents | Change |
|---|---|---|
| FY2025 | $716M | $-237M |
| FY2024 | $953M | +$249M |
| FY2023 | $704M | +$14M |
| FY2022 | $690M | $-117M |
| FY2021 | $806M | — |
More SAME DATA, OTHER VIEWS
Cash & equivalents across coverage → · PODD company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.